13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 54 holding rows worth $331,044,132.
- Accession
- 0001420506-24-002434
- Filer
- CIK 1595851
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 54 entries on the cover page, a total value of $331,044,132 stated on the cover page (in dollars after the unit check, H1), rows summing to $331,044,132 with VALUE read as dollars as filed, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $29,640,000 | dollars as filed | put |
| BIOHAVEN LTD | G1110E907 | COM | 348,778 | $17,428,437 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 120,000 | $14,986,800 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 110,000 | $13,097,700 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 140,000 | $12,950,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 135,000 | $12,132,450 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 350,000 | $11,511,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 750,000 | $10,012,500 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 250,000 | $9,432,500 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 800,000 | $9,232,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 80,000 | $9,141,600 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 140,000 | $8,863,400 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 450,000 | $8,662,500 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 190,000 | $8,631,700 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 52,500 | $7,838,775 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 150,000 | $7,665,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 150,000 | $7,573,500 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 310,000 | $7,250,900 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,474,995 | $7,153,726 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 375,000 | $6,780,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 128,411 | $6,474,483 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 535,000 | $6,387,900 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 215,000 | $6,129,650 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 75,000 | $5,475,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 195,000 | $5,204,550 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 450,000 | $4,932,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 220,000 | $4,538,600 | dollars as filed | put |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 175,000 | $4,455,500 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,150,000 | $4,321,500 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 78,842 | $4,130,532 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 650,000 | $3,848,000 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 110,000 | $3,676,200 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 50,000 | $3,650,000 | dollars as filed | call |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 100,000 | $3,592,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 145,000 | $3,571,350 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 160,000 | $3,300,800 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 300,000 | $3,134,988 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 1,350,000 | $3,091,500 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 725,000 | $3,074,000 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 1,500,000 | $2,895,000 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 265,000 | $2,779,850 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 500,000 | $2,640,000 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 550,000 | $2,101,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 50,000 | $2,098,000 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 125,000 | $1,901,250 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 65,000 | $1,874,600 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 85,000 | $1,861,500 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 60,000 | $1,764,600 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 75,000 | $1,706,250 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 887,700 | $1,615,614 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 800,000 | $1,408,000 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 200,000 | $1,310,000 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 160,898 | $1,061,927 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 325,000 | $1,053,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-002434 | this filing | 2024-11-14 | acceptance time not in the bulk data set |